XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.

XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.

Item
http://www.wikidata.org/entity/Q37292735
RAD52 variants predict platinum resistance and prognosis of cervical cancer.Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjectsTranslational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms.γ-Glutamyl hydrolase modulation and folate influence chemosensitivity of cancer cells to 5-fluorouracil and methotrexateThe association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancerABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?Clinicopathological and functional significance of XRCC1 expression in ovarian cancer.γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells.XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
P2860

XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.

Item
http://www.wikidata.org/entity/Q37292735
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@en
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@nl
type
label
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@en
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@nl
prefLabel
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@en
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
XRCC1 Arginine194Tryptophan an ...... emotherapy in cervical cancer.
@en
P2093
P304
P31
P356
10.1016/J.YGYNO.2008.08.034
P407
P433
P478
P577
P698
P921